title: Structural model of antagonist and agonist binding to the angiotensin II, AT1 subtype, G protein coupled receptor.
abstract: BACKGROUND
  The family of G protein coupled receptors is the largest and perhaps most functionally diverse class of cell-surface receptors. Due to the difficulty of obtaining structural data on membrane proteins there is little information on which to base an understanding of ligand structure-activity relationships, the effects of receptor mutations and the mechanism(s) of signal transduction in this family. We therefore set out to develop a structural model for one such receptor, the human angiotensin II receptor.
  
  
  RESULTS
  An alignment between the human angiotensin II (type 1; hAT1), human beta 2 adrenergic, human neurokinin-1, and human bradykinin receptors, all of which are G protein coupled receptors, was used to generate a three-dimensional model of the hAT1 receptor based on bacteriorhodopsin. We observed a region within the model that was congruent with the biogenic amine binding site of beta 2, and were thus able to dock a model of the hAT1 antagonist L-158,282 (MK-996) into the transmembrane region of the receptor model. The antagonist was oriented within the helical domain by recognising that the essential acid functionality of this antagonist interacts with Lys199. The structural model is consistent with much of the information on structure-activity relationships for both non-peptide and peptide ligands.
  
  
  CONCLUSIONS
  Our model provides an explanation for the conversion of the antagonist L-158,282 (MK-996) to an agonist by the addition of an isobutyl group. It also suggests a model for domain motion during signal transduction. The approach of independently deriving three-dimensional receptor models and pharmacophore models of the ligands, then combining them, is a powerful technique which helps validate both models.
authors.affiliation: Merck Research Laboratories, Rahway, NJ 07065, USA.
authors.forename: D J
authors.initials: DJ
authors.lastname: Underwood
authors.forename: C D
authors.initials: CD
authors.lastname: Strader
authors.forename: R
authors.initials: R
authors.lastname: Rivero
authors.forename: A A
authors.initials: AA
authors.lastname: Patchett
authors.forename: W
authors.initials: W
authors.lastname: Greenlee
authors.forename: K
authors.initials: K
authors.lastname: Prendergast
mesh_terms: D000595:Amino Acid Sequence; D000803:Angiotensin I / Q000378:metabolism*; D000804:Angiotensin II / Q000378:metabolism*; D057911:Angiotensin Receptor Antagonists; D019204:GTP-Binding Proteins / Q000378:metabolism*; D006801:Humans; D008961:Models, Structural; D008969:Molecular Sequence Data; D011945:Receptors, Angiotensin / Q000819:agonists*
chemical_list: D057911:Angiotensin Receptor Antagonists; D011945:Receptors, Angiotensin; D000804:Angiotensin II; D000803:Angiotensin I; D019204:GTP-Binding Proteins